Peroxisome proliferator-activated receptors (PPARS): Regulators of gene expression in heart and skeletal muscle

Acta Physiologica Scandinavica

Volumn 178, Issue 4, 2003, Pages 425-434

  Gilde, A J ^a   Van Bilsen, M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiac muscle; Fatty acids; Metabolism; Skeletal muscle; Transcription

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; ACYL COENZYME A DEHYDROGENASE; ACYL COENZYME A OXIDASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C3; CARNITINE PALMITOYLTRANSFERASE; CARRIER PROTEIN; CIGLITAZONE; FATTY ACID BINDING PROTEIN; HORMONE RECEPTOR; LIGAND; LIPOPROTEIN LIPASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; FATTY ACID TRANSPORT; GENE EXPRESSION REGULATION; HEART MUSCLE; HUMAN; LIPID METABOLISM; MUSCLE METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; FATTY ACIDS; GENE EXPRESSION REGULATION; HEART; HUMANS; HYPOGLYCEMIC AGENTS; ISOMERISM; LIGANDS; MICE; MUSCLE, SKELETAL; PHOSPHORYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0042405041     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2003.01161.x     Document Type: Conference Paper

References (80)

1. Aperlo, C., Pognonec, P., Saladin, R., Auwerx, J. & Boulukos, K.E. 1995. cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPARγ. Gene 162, 297-302.
2. Barger, P.M., Brandt, J.M., Leone, T.C., Weinheimer, C.J. & Kelly, D.P. 2000. Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth. J Clin Invest 105, 1723-1730.
3. Barger, P.M., Browning, A.C., Garner, A.N. & Kelly, D.P. 2001. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol Chem 276, 44495-44501.
4. Berger, J., Leibowitz, M.D., Doebber, T.W. et al. 1999. Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects. J Biol Chem 274, 6718-6725.
5. Braissant, O., Foufelle, F., Scotto, C., Dauça M. & Wahli, W. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ, in the adult rat. Endocrinology 137, 354-366.
6. Brandt, J.M., Djouadi, F. & Kelly, D.P. 1998. Fatty acids activate transcription of the muscle carnitine palmitoyl-transferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α. J Biol Cbem 273, 23786-23792.
7. Camp, H.S. & Tafuri, S.R. 1997. Regulation of peroxisome proliferator-activated receptory activity by mitogen-activated proteinkinase. J Biol Chem 272, 10811-10816.
8. Camp, H.S., Tafuri, S.R. & Leff, T. 1999. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity. Endocrinology 140, 392-397.
9. Cha, B.S., Ciaraldi, T.P., Carter, L. et al. 2001. Peroxisome proliferator-activated receptor (PPAR) γ and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 44, 444-452.
10. Chawla, A., Barak, Y., Nagy, L, Liao, D., Tontonoz, P. & Evans, R.M. 2001. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7, 48-52.
11. Chevillotte, E., Rieusset, J., Roques, M., Desage, M. & Vidal, H. 2001. The regulation of uncoupling protein-2 gene expression by omega-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor beta. J Biol Chem 276, 10853-10860.
12. Cresci, S., Wright, L.D., Spratt, J.A., Briggs, F.N. & Kelly, D.P. 1996. Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle. Am J Physiol 270, C1413-C1420.
13. Dowell, P., Ishmael, J.E., Avram, D., Peterson, V.J., Nevrivy, D.J. & Leid, M. 1999. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor interacting protein. J Biol Chem 274, 15901-15907.
14. Elholm, M., Dam, I., Jorgensen, C. et al. 2001. Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with co-factors. J Biol Chem 276, 21410-21416.
15. Escher, P., Braissant, O., Basu-Modak, S., Michalik, L., Wahli, W. & Desvergne, B. 2001. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142, 4195-4202.
16. Fajas, L., Auboeuf, D., Raspe, E. et al. 1997. The organization, promoter analysis, and expression of the human PPAR-gamma gene. J Biol Chem 272, 18779-18789.
17. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812.
18. Forman, B.M., Chen, J. & Evans, R.M. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci USA 94, 4312-4317.
19. Gelman, L., Zhou, G., Fajas, L., Raspé, E., Fruchart, J.-C. & Auwerx, J. 1999. p300 interacts with the N- and C-terminal part of PPARγ 2 in a ligand-independent and -dependent manner, respectively. J Biol Chem 274, 7681-7688.
20. Gervois, P., Torra, I.P, Chinetti, G. et al. 1999. A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity. Mol Endocrinol 13, 1535-1549.
21. Gottlicher, M., Widmark, E., Li, Q. & Gustafsson, J.A. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89, 4653-4657.
22. Han, C., Demetris, A.J., Michalopoulos, G., Shelhamer, J.H. & Wu, T. 2002. 85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am J Physiol 282, G586-G597.
23. Hanselman, J.C., Vartanian, M.A., Koester, B.P. et al. 2001. Expression of the mRNA encoding truncated PPAR alpha does not correlate with hepatic insensitivity to peroxisome proliferators. Mol Cell Biochem 217, 91-97.
24. Huss, J.M., Levy, F.H. & Kelly, D.P. 2001. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 276, 27605-27612.
25. Issemann, I. & Green, S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
26. Issemann, I., Prince, R.A., Tugwood, J.D. & Green, S. 1993. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. Mol Endocrinol 11, 37-47.
27. Jamshidi, Y., Montgomery, H.E., Hense, H.W. et al. 2002. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation 105, 950-955.
28. Johnson, T.E., Holloway, M.K., Vogel, R. et al. 1997. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors. J Steroid Biochem Mol Biol 63, 1-8.
29. Juge-Aubry, C.E., Gorla-Bajszczak, A., Pernin, A. et al. 1995. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J Biol Chem 270, 18117-18122.
30. Juge-Aubry, C.E., Hammar, E., Siegrist-Kaiser, C. et al. 1999. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem 274, 10505-10510.
31. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A. & Evans, R.M. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774.
32. Kliewer, S.A., Forman, B.M., Blumberg, B. et al. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91, 7355-7359.
33. Kliewer, S.A., Sundseth, S.S., Jones, S.A. et al. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94, 4318-4323.
34. Krey, G., Braissant, O., L-Horset, F. et al. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11, 779-791.
35. Krogsdam, A.M., Nielsen, C.A., Neve, S. et al. 2002. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. Biochem J 363, 157-165.
36. Lapsys, N.M., Kriketos, A.D., Lim-Fraser, M. et al. 2000. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab 85, 4293-4297.
37. Lavinsky, R.M., Jepsen, K., Heinzel, T. et al. 1998. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA 95, 2920-2925.
38. Lehman, J.J., Barger, P.M., Kovacs, A., Saffitz, J.E., Medeiros, D.M. & Kelly, D.P. 2000. Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106, 847-856.
39. Lennon, A.M., Ramauge, M., Dessouroux, A. & Pierre, M. 2002. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-delta 12-14-prostaglandin J2 and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J Biol Chem 277, 29681-29685.
40. Leone, T.C., Weinheimer, C.J. & Kelly, D.P. 1999. A critical role for the peroxisome proliferator-activated receptor (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96, 7473-7478.
41. Lin, J., Puigserver, P., Donovan, J., Tarr, P. & Spiegelman, B.M. 2002a. Peroxisome proliferator-activated receptor gamma coactivator1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 277, 1645-1648.
42. Lin, J., Wu, H., Tarr, P.T. et al. 2002b. Transcriptional co-activator PGC-1alpha drives the formation of slow-twitch muscle fibres. Nature 418, 797-801.
43. McKenna, N.J., Lanz, R.B. & O'Malley, B.W. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocrine Rev 20, 321-344.
44. Marcus, S.L., Capone, J.P. & Rachubinski, R.A. 1996. Identification of COUP-TFII as a peroxisome proliferator response element binding factor using genetic selection in yeast: COUP-TFII activates transcription in yeast but anatogonizes PPAR signaling in mammalian cells. Mol Cell Endocrinol 120, 31-39.
45. Mascaro, C., Acosta, E., Ortiz, J.A., Marrero, P.F., Hegardt, F.G. & Haro, D. 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273, 8560-8563.
46. Meier-Heusler, S.C., Zhu, X., Juge-Aubry, C. et al. 1995. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbAα 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition. Mol Cell Endocrinol 107, 55-66.
47. Miyata, K.S., Zhang, B., Marcus, S.L., Capone, J.P. & Rachubinski, R.A. 1993. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated sigaling. J Biol Chem 268, 19169-19172.
48. Miyata, K.S., McCaw, S.E., Meertens, L.M., Patel, H.V., Rachubinski, R.A. & Capone, J.P. 1998. Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor α and liver-X-receptor α. Mol Cell Endocrinol 146, 69-76.
49. Muoio, D.M., MacLean, P.S., Lang, D.B. et al. 2002a. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem 277, 26089-26097.
50. Muoio, D.M., Way, J.M., Tanner, C.J. et al. 2002b. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51, 901-909.
51. Murakami, K., Ide, T., Suzuki, M., Mochizuki, T. & Kadowaki, T. 1999. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor α. Biochem Biophys Res Commun 260, 609-613.
52. Murakami, K., Ide, T., Nakazawa, T., Okazaki, T., Mochizuki, T. & Kadowaki, T. 2001. Fatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonists. Biochem J 353, 231-238.
53. Park, K.S., Ciaraldi, T.P., Abrams-Carter, L., Mudaliar, S., Nikoulina, S.E. & Henry, R.R. 1997. PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46, 1230-1234.
54. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M. & Spiegelman, B.M. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839.
55. 2/retinoid X receptor α-activated transcription from the murine lipoprotein lipase promoter. Endocrinology 140, 1586-1593.
56. Takano, H., Nagai, T., Asakawa, M. et al. 2000. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Circ Res 87, 596-602.
57. Tan, N.S., Shaw, N.S., Vinckenbosch, N. et al. 2002. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22, 5114-5127.
58. Teboul, L., Galliard, D., Staccini, L., Inadera, H., Amri, E.-Z. & Grimaldi, P.A. 1995. Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 270, 28183-28187.
59. Tsai, M.J. & O'Malley, B.W. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann Rev Biochem 63, 451-486.
60. Tunstall, R.J., Mehan, K.A., Wadley, G.D. et al. 2002. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol 283, E66-E72.
61. Van Bilsen, M., van der Vusse, G.J. & Reneman, R.S. 1998. Transcriptional regulation of metabolic processes: implications for cardiac metabolism. Pflügers Arch 437, 2-14.
62. Van Bilsen, M., Van der Vusse, G.J., Glide, A.J., Lindhout, M. & Van der Lee, K.A.J.M. 2002. Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression. Mol Cell Biochem 239, 131-138.
63. Van der Lee, K.A.J.M., Vork, M.M., De Vries, J.E. et al. 2000a. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res 41, 41-47.
64. Van der Lee, K.A.J.M., Willemsen, P.H.M., Van der Vusse, G.J. & van Bilsen, M. 2000b. Effects of fatty acids on uncoupling protein-2 expression in the rat heart. FASEB J 14, 495-502.
65. Van der Vusse, G.J., Glatz, J.F.C., Stam, H.C.G. & Reneman, R.S. 1992. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72, 881-940.
66. Vega, R.B., Huss, J.M. & Kelly, D.P. 2000. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20, 1868-1876.
67. Vidal-Puig, A.J., Considine, R.V., Jimenez-Liñan, M. et al. 1997. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucorticoids. J Clin Invest 99, 2416-2422.
68. Watanabe, K., Fujii, H., Takahashi, T. et al. 2000. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity. J Biol Chem 275, 22293-22299.
69. Winrow, C.J., Kassam, A., Miyata, K.S. et al. 1996. Interplay of the peroxisome proliferator-activated receptor and the thyroid hormone receptor-signaling pathways in regulating peroxisome proliferator-responsive genes. Ann N Y Acad Sci 804, 214-230.
70. Wolfrum, C., Borrmann, C.M., Borchers, T. & Spener, F. 2001. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci USA 98, 2323-2328.
71. Wu, Q. & Haunerland, N.H. 2001. A novel fatty acid response element controls the expression of the flight muscle FABP gene of the desert locust, Schistocerca gregaria. Eur J Biochem 268, 5894-5900.
72. Wu, P., Peters, J.M. & Harris, R.A. 2001. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun 287, 391-396.
73. Wurch, T., Junquero, D., Delhon, A. & Pauwels, J. 2002. Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor. Naunyn Schmiedebergs Arch Pharmacol 365, 133-140.
74. Xu, H.E., Lambert, M.H., Montana, V.G. et al. 1999. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3, 397-403.
75. Yoon, J.C., Puigserver, P., Chen, G. et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131-138.
76. Young, M.E., Goodwin, G.W., Ying, J. et al. 2001a. Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids. Am J Physiol 280, E471-E479.
77. Young, M.E., Razeghi, P., Cedars, A.M., Guthrie, P.H. & Taegtmeyer, H. 2001b. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 89, 1199-1208.
78. Zhu, Y., Qi, C., Calandra, C., Rao, M.S. & Reddy, J.K. 1996. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ. Gene Expr 6, 185-195.
79. Zhu, Y., Qi, C., Jain, S., Rao, M.S. & Reddy, J.K. 1997. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J Biol Chem 272, 25500-25506.
80. Zierath, J.R., Ryder, J.W., Doebber, T. et al. 1998. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARγ agonist) action. Endocrinology 139, 5034-5041.